⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Remedica Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Remedica Ltd.
↗Limassol, Cyprus
Remedica is a leading Cyprus-based pharmaceutical company founded in 1980. It specializes in the development, manufacturing, and distribution of a wide range of high-quality generic and over-the-counter (OTC) pharmaceutical products, with a portfolio exceeding 300 medications.
The company maintains a significant global footprint, exporting products to over 140 countries. Its manufacturing facilities are internationally recognized, adhering to stringent quality standards and GMP certifications, and it serves various therapeutic areas including oncology, cardiovascular, central nervous system (CNS), and anti-infectives.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Founded:1980
Ownership:subsidiary
Status:operating
FUNDING
Investors:Ascendis Health Limited, Blantyre Capital, Cambridge Capital, L1 Health
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Ascendis Health Limited
Acquired By:Ascendis Health Limited (2016-08-01)
Key Partnerships:Global distribution network covering 140+ countries
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Dr. Michael Neoptolemou - CEO
Scientific Founders:Takis Pattichis
LINKS
Website:remedica.eu
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Remedica Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.